Status
Conditions
Treatments
About
The aim of this study is to evaluate the efficacy of ursodeoxycholic acid as local drug delivery agent in intra- bony defect to achieve bone regeneration.
Full description
Experimental: Main treatment group the prepared UDCA gel will be injected using a syringe with blunt cannula into the defect site.
Comparator: In patients allocated to control group, placebo gel will be injected in to the defect site using a syringe with blunt cannula.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
26 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
R V Chandra, MDS;DNB;PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal